Health AI in the 3rd Week of April

Apple (US): Apple secured FDA-cleared diagnostic radiology use for Studio Display XDR through its medical imaging calibration feature on macOS. [Link]

Meta (US): Meta launched Muse Spark, a multimodal AI model designed to reason across text and images, including health-related questions. It is not a healthcare product, but it shows how frontier AI models are starting to build health into their core capabilities. [Link]

AWS (US): AWS launched Amazon Bio Discovery, an AI platform that helps researchers use biological models and lab partners to speed up drug discovery. It shows AWS moving further into AI tools for biotech research. [Link]

Evergreen Nephrology (US): Evergreen Nephrology launched Evergreen Connected Care with Phamily, using AI to support ongoing kidney care management. [Link]

Covista (US): announced an AI-powered healthcare education initiative with Google Cloud and made its healthcare AI credentials available across all five institutions. [Link]

Institute of Cancer Research (UK): Developed PhenMap, an AI tool to predict which bowel cancer patients will respond to bevacizumab, helping avoid ineffective treatment and side effects. [Link]

Manatt Health (US): Published a health AI policy tracker outlining growing U.S. legislative activity, including rules on chatbot transparency, patient consent, and payer use of AI. [Link]

European Commission (EU): Highlighted EU-backed AI projects across healthcare and other sectors, including clinical guidance, disease prevention, and diagnostics. [Link]

MHRA (UK): Secured £3.6 million to expand its AI Airlock programme, supporting longer-term real-world testing of AI medical devices and a more sustainable regulatory pathway for future tools. [Link]

Efficacy of a Conversational AI Agent for Psychiatric Symptoms and Digital Therapeutic Alliance: A trial of 995 students found conversational AI improved anxiety and well-being, with some effect on depression. [Link]

Large Language Model Performance and Clinical Reasoning Tasks: Evaluated 21 LLMs across 29 clinical scenarios, finding strong performance in final diagnosis but poor accuracy in differential diagnosis. [Link]

Unified multimodal learning for stroke triage: Built a multimodal AI integrating CT imaging for stroke triage with sub-minute inference times. [Link]

Trust, Truth, and Transparency: Analysing the References Underpinning AI-Generated Surgical Information: Found that the worst-performing AI models produced 34% fabricated or unverifiable references when answering common surgical questions. [Link]

Graphicalized vision-language modelling for comprehensive lung nodule analysis and risk stratification: Combined PET/CT imaging with radiology text for lung nodule analysis and risk stratification. It points to multimodal AI moving beyond simple detection toward more integrated clinical assessment.[Link]

Oxford University : Developed an AI tool that detects subtle changes in fat around the heart on routine cardiac CT scans to predict heart failure risk up to five years earlier. [Link]

EcoRxAgent: an AI agent for generating economically substitutable prescriptions: Built an AI agent to generate lower-cost prescription alternatives while maintaining therapeutic non-inferiority and safety checks. [Link]

WHOOP (US): WHOOP Physician Services was selected for CMS’s ACCESS program, allowing eligible Medicare beneficiaries to receive WHOOP and a technology-enabled care programme for chronic condition management. [Link]

WellSky (US): Expanded its partnership with Google Cloud to embed AI into WellSky CarePort and improve provider directory accuracy for hospital discharge planning. [Link]

Optum Arcadia (US): Partnered with Kivo Health to expand AI-powered, at-home pulmonary rehabilitation and care for eligible patients in California with chronic lung disease, including COPD. [Link]

Creative Solutions in Healthcare (US): Partnered with ExaCare AI to roll out an AI-powered preadmission platform across 160 skilled nursing facilities, processing more than 1,500 referrals within the first 48 hours. [Link]

Amigo (US): Partnered with Heal to expand patient-facing clinical AI across Saudi Arabia, with support for Arabic models trained on Saudi dialect for workflows such as intake, triage, care navigation, and 24/7 patient support. [Link]

Warrington Innovation Network Primary Care Network (UK): Partnered with Aide Health to roll out an AI-powered app across six GP surgeries to support patients with long-term conditions including COPD, obesity, and hypertension. [Link]

PortmanDentex (UK): Signed a two-year partnership with Heidi to deploy ambient clinical documentation tools across its dental practices in the UK and Ireland. [Link]

Novo Nordisk (Denmark): Announced a strategic partnership with OpenAI to apply advanced AI across drug discovery, manufacturing, and commercial operations. The collaboration will use AI to analyse complex datasets, identify drug candidates, and improve efficiency across the pipeline. [Link]

Tandem Health (Sweden): Partnered with Humanitas to enter Italy and deploy AI into clinical workflows. It reflects ambient clinical documentation moving beyond pilots into routine use in European care settings. [Link]

Luminai (US): Raised $38 million to automate complex healthcare revenue cycles. [Link]

Helical (Europe): Secured $10 million to build a virtual lab for computational drug testing. [Link]

Ultralight (US): Raised $9.3 million for an AI-native direct primary care operating system. [Link]

Wavelet Medical (US): Partnered with Aegis Ventures to develop and scale a non-invasive AI-powered fetal EEG monitoring platform, alongside $7 million in seed funding. [Link]

Eka Ventures (UK): Launched an £80 million second fund to back early-stage UK startups in health, wellbeing, and sustainability [Link]

Newfund (France): Closed HEKA, a €60 million fund dedicated to BrainTech startups, including companies working across AI, digital therapeutics, advanced imaging, and biotech. [Link]

Function Health (US): Acquired Getlabs to integrate at-home and in-office mobile phlebotomy services into its diagnostic platform, expanding access to lab testing beyond physical locations. [Link]

TELCOR (US): Acquired Sample Healthcare to add AI-powered workflow execution into revenue cycle operations, including prior authorizations, appeals, payer follow-up, and document processing. [Link]

Catalyst Crew Technologies (US): Acquired AI healthcare IP including CardioAI, PulmoAI, and NeuroAI, and bought Inversiones Long 33 as its operating arm in Venezuela. [Link]